WHO-IARC (International Agency for Research on Cancer)

Grantee Website Lyon, France
Purpose
To verify effectiveness and safety of a reduced dose schedule of HPV vaccine in preventing cervical cancer to facilitate the rapid introduction of HPV vaccine programs in poor countries with high cervical cancer rates
Division
Global Health
Date
MAY 2021
Region Served
GLOBAL
Committed Amount
$7,646,750
Grant Topic
Vaccine Development
Duration (Months)
63
Grantee Location
Lyon, France

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.